Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jefferson Rios Pimenta"'
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 904-910 (2020)
Metastatic pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. Until recently, cytotoxic chemotherapy was the only treatment option. Currently, there are subgroups of patients with PDAC either with somatic or germline mutations who are ca
Externí odkaz:
https://doaj.org/article/32e3b22850064249aa77cdaf835e637a
Publikováno v:
Journal of Gastrointestinal Cancer. 52:784-787
Publikováno v:
Case Reports in Oncology. 13:904-910
Metastatic pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. Until recently, cytotoxic chemotherapy was the only treatment option. Currently, there are subgroups of patients with PDAC either with somatic or germline mutations who are ca
Autor:
Taciana Sousa Mutao, Angel Ayumi Tome Uchiyama, Pedro Alexandre Ismael Amaral Silva, Denis S Shimba, Larissa Machado, Eliza Dalsasso Ricardo, Moisés de Souza Martins Lopes, Cheng T Yen, Jefferson Rios Pimenta, Renata D'Alpino Peixoto
Publikováno v:
Current Oncology
Current Oncology, Vol 28, Iss 76, Pp 783-799 (2021)
Current Oncology, Vol 28, Iss 76, Pp 783-799 (2021)
Proton pump inhibitors (PPIs) are the most commonly used anti-acid drugs worldwide, including among cancer patients. However, drug-drug interactions between PPIs and other agents may lead to decreased drug absorption with possible reduced therapeutic
Autor:
Ricardo Caponero, Marcos Mota do Carmo Costa, Marcelo Volpon Santos, Ariel Galapo Kann, Felipe Ades, Jefferson Rios Pimenta, Larissa Machado, Eliza Dalsasso Ricardo, Renata D'Alpino Peixoto, Taciana Sousa Mutao, Carlos Henrique A. Teixeira, Waldec Jorge, Cheng Tzu
Publikováno v:
Journal of Clinical Oncology. 38:e19261-e19261
e19261 Background: MDTB have emerged as a valuable forum to address questions related to patient management. There is a general data lack of its overall benefit by attending physicians. However, few reports describe numerical impact on patient care o
Autor:
Alexandre Andre Balieiro Anastacio da Costa, Tiago Felismino, José Augusto Rinck, Victor Hugo Fonseca de Jesus, Daniel Vilarim Araujo, Jefferson Rios Pimenta
Publikováno v:
Journal of Clinical Oncology. 36:e24038-e24038
e24038Background: Immunotherapy is a standard treatment in metastatic cutaneous melanoma (mCM). Yet it still lacks adequate predictors of response. The NLR is a prognostic factor in mCM. We aim to ...